Package Leaflet: Information for the User
Quetiapine Normon 50 mg Film-Coated Tablets
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Quetiapine Normon contains a substance called quetiapine. It belongs to a group of medications called antipsychotics. Quetiapine can be used to treat several diseases, such as:
Your doctor may continue to prescribe quetiapine to you even when you are feeling better.
Do not take Quetiapine Normon
If you are allergic to quetiapine or any of the other components of this medication (listed in section 6).
If you are taking any of the following medications:
If you have any doubts, consult your doctor or pharmacist before taking quetiapine.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take quetiapine:
Tell your doctor immediately if, after taking quetiapine, you experience any of the following:
These disorders may be caused by this type of medication.
Tell your doctor as soon as possible if you have:
If you ever think about harming yourself or committing suicide, contact your doctor or go to a hospital immediately. It may be helpful to tell a family member or close friend that you are depressed and ask them to read this package leaflet. You can ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Severe Skin Reactions (SCARs)
With the use of this medication, very rare but severe skin reactions (SCARs) have been reported, which can be life-threatening or fatal. These are commonly manifested as:
If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.
Weight Gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and Adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
Other Medications and Quetiapine Normon
Tell your doctor if you are taking, have recently taken, or may take any other medication.
Do not take quetiapine if you are using any of the following medications:
Tell your doctor if you are using any of the following medications:
Taking Quetiapine Normon with Food, Drinks, and Alcohol
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. You should not take quetiapine during pregnancy, unless you have discussed it with your doctor. You should not use quetiapine if you are breastfeeding.
The following symptoms, which may represent a withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and Using Machines
These tablets may make you feel drowsy. Do not drive or operate tools or machines until you know how the tablets affect you.
Quetiapine Normon Contains Lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Quetiapine Normon Contains Sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Effect on Urine Drug Tests
If you are undergoing a urine drug test, taking quetiapine may produce positive results for methadone or certain antidepressants called tricyclic antidepressants (TCAs) when using some analysis methods, even if you are not taking methadone or TCAs. If this occurs, a more specific test can be performed.
Follow the administration instructions for this medication exactly as indicated by your doctor. If you have any doubts, consult your doctor or pharmacist again.
Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your disease and needs, but it is usually between 150 mg and 800 mg.
Liver Problems
If you have liver problems, your doctor may change your dose.
Elderly People
If you are elderly, your doctor may change your dose.
Use in Children and Adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
If You Take More Quetiapine Normon Than You Should
If you take more quetiapine than your doctor has prescribed, you may feel drowsy, dizzy, and experience abnormal heartbeats.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If You Forget to Take Quetiapine Normon
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then.
Do not take a double dose to make up for forgotten doses.
If You Stop Taking Quetiapine Normon
If you stop taking quetiapine abruptly, you may be unable to sleep (insomnia), or you may feel nauseous, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest gradually reducing the dose before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Very Common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very Rare: may affect up to 1 in 10,000 people
Not Known: frequency cannot be estimated from the available data
The class of medicines to which quetiapine belongs may cause heart rhythm problems that can be serious and, in severe cases, may be fatal.
Some adverse effects are only observed when a blood test is performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increase in liver enzymes, decrease in the number of certain types of blood cells, decrease in the number of red blood cells, increase in creatine phosphokinase in the blood (a substance found in muscles), decrease in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. The increases in prolactin hormone may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Other Adverse Effects in Children and Adolescents
The same adverse effects that can occur in adults can also occur in children and adolescents.
The following adverse effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very Common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es/. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the blister after "CAD". The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines that you no longer need in the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This will help protect the environment.
Composition of Quetiapine Normon
Appearance of the Product and Package Contents
Quetiapine Normon 50 mg film-coated tablets are presented in the form of white, round, and biconvex tablets, with a break line on one face and smooth on the other face, with a diameter of 7.6 mm ± 10%.
They are presented in aluminum/PVC blisters of 60 tablets.
Marketing Authorization Holder and Manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 - 28760 Tres Cantos - Madrid (SPAIN).
Date of the Last Revision of this Leaflet: May 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/